Health & Wellness
Thursday, May 28, 2026 · Butte
Lupus Trial Shows Patients Halting Medications After Immune Treatment
Researchers report that patients enrolled in a trial of an experimental immune-resetting treatment have stopped taking medications to manage lupus, a chronic autoimmune disease. The approach represents a potential shift in how doctors manage the condition.
Safety inquiry finds 78 children received gender medication at Brighton clinic without required checks
An independent safety inquiry found that 78 children at a Brighton gender care clinic received medication without undergoing required medical assessments. The investigation identified gaps in clinical protocols at WellBN.
Thursday, May 28, 2026
Medicare Advantage insurers denied long-term care authorizations at high rates, HHS inspector general reports
The Department of Health and Human Services inspector general found that three major Medicare Advantage insurers denied prior authorization requests for long-term care services at rates exceeding those of competitors. The report examined denial patterns across multiple plans.
Thursday, May 28, 2026
Ebola cases rise in Congo and Uganda as health officials assess outbreak response
The Ebola outbreak spreading across the Democratic Republic of the Congo and Uganda has accelerated in recent weeks. Health officials and aid organizations are now evaluating the resources and personnel dedicated to containing the virus.
Thursday, May 28, 2026
Pig Kidney Transplants Gain Momentum as Organ Shortage Persists
More than 90,000 people in the U.S. live with kidney failure, according to the National Kidney Foundation. Xenotransplantation, which involves transplanting animal organs into human recipients, represents a possible solution to chronic organ shortages.
Thursday, May 28, 2026
Trump administration issues compliance notices to over 500 hospitals for lack of price disclosure
The Trump administration has sent warnings to more than 500 hospitals, citing failures to publicly disclose pricing information. Officials argue the lack of transparency artificially inflates healthcare expenses.
Thursday, May 28, 2026
Older U.S. Students' Test Scores Plateau While Younger Peers Recover from Pandemic
The federal government released test results Wednesday showing a split pattern in student performance. Younger students have regained academic ground after pandemic disruptions, while older students' scores in reading and math remain flat.
Thursday, May 28, 2026
CDC trust splits evenly among U.S. adults, with Republicans showing increased confidence
A new poll found that 50% of American adults trust CDC public health recommendations while 50% do not. Republican voters registered the largest year-over-year increase in confidence, rising to 67% from 63%.
Thursday, May 28, 2026
Researchers investigate how GLP-1 drugs may lower cancer risk
Studies suggest GLP-1 medications may help prevent cancer and slow its progression. Researchers are exploring whether the drugs work through weight loss alone or through additional metabolic pathways.
Thursday, May 28, 2026
Researchers investigate how GLP-1 drugs may lower cancer risk
Studies suggest GLP-1 medications may help prevent cancer and slow its progression. Researchers are exploring whether the drugs work through weight loss alone or through additional metabolic pathways.
Thursday, May 28, 2026
Cancer survival rates climb as mental health challenges emerge
More Americans are surviving cancer than ever before, thanks to advances in treatment and screening methods. Yet survivors often face persistent mental health struggles long after their medical treatment ends.
Thursday, May 28, 2026
Cambridge Scientists Test First AI-Designed Vaccine in Human Trial
Scientists at Cambridge University have conducted the first human trial of a vaccine designed by artificial intelligence. The AI-created vaccine aims to protect against multiple related viruses rather than a single pathogen.
Thursday, May 28, 2026
Cambridge Scientists Test First AI-Designed Vaccine in Human Trial
Scientists at Cambridge University have conducted the first human trial of a vaccine designed by artificial intelligence. The AI-created vaccine aims to protect against multiple related viruses rather than a single pathogen.
Thursday, May 28, 2026
Remote workers show higher rates of depression and anxiety, study finds
A study in the journal Science found that remote workers reported more depression, anxiety, and visits to mental health professionals than workers in jobs requiring on-site presence. Researchers said the findings do not support forcing all employees back to offices.
Thursday, May 28, 2026
Remote workers show higher rates of depression and anxiety, study finds
A study in the journal Science found that remote workers reported more depression, anxiety, and visits to mental health professionals than workers in jobs requiring on-site presence. Researchers said the findings do not support forcing all employees back to offices.
Thursday, May 28, 2026
CDC investigates Listeria outbreak connected to soft ricotta and requesón cheese
The Centers for Disease Control and Prevention is investigating a Listeria outbreak tied to soft ricotta and requesón cheese products. The agency has identified multiple cases across several states and recommends consumers check their refrigerators for affected items.
Thursday, May 28, 2026
Ebola vaccine gap widens as Congo outbreak spreads without approved treatment
Health authorities have an effective Ebola vaccine, but it does not protect against the strain circulating in the Democratic Republic of Congo. Researchers are testing several vaccine candidates to address the outbreak.
Thursday, May 28, 2026
Some Jurisdictions Curtail Public Health Powers Following Pandemic Disputes
Several jurisdictions have restricted the powers of their public health agencies following backlash over pandemic-era policies. The changes come amid ongoing debates over lockdowns, mask mandates, and vaccine requirements.
Thursday, May 28, 2026
Weekly Semaglutide Improves Quality of Life for Patients With Diabetes and Kidney Disease
Researchers presenting findings from the FLOW trial at the 63rd European Renal Association Congress reported that weekly semaglutide injections improved health-related quality of life measures among adults with diabetes and kidney disease.
Thursday, May 28, 2026
Semaglutid improves quality of life for patients with diabetes and kidney disease, study finds
Researchers presenting findings at the ERA Congress in Glasgow reported that weekly semaglutid injections improved health-related quality of life measures in adults with type 2 diabetes and chronic kidney disease.
Thursday, May 28, 2026
Semaglutide Study Shows Quality-of-Life Improvements in Diabetic Patients With Kidney Disease
New findings from a major clinical trial indicate that semaglutide improves quality of life in patients who have both type 2 diabetes and chronic kidney disease. Researchers presented the results at a medical conference in Glasgow.
Thursday, May 28, 2026
WHO Chief: Congo Ebola Response Still Lagging Despite Testing Gains
The World Health Organization acknowledged Wednesday that Congo's Ebola outbreak maintains an advantage over response teams even as testing capabilities improve. Armed attacks in the region compound the challenge.
Thursday, May 28, 2026
Experimental daily pill extends pancreatic cancer survival
Researchers have developed an experimental drug that extends survival for pancreatic cancer patients by slowing disease progression. The once-daily pill represents progress in treating one of the deadliest cancers.
Thursday, May 28, 2026
U.S. Coordinates Ebola Response in Central Africa
The U.S. State Department, working with the CDC and regional governments, has committed over $162 million to combat an ongoing Ebola outbreak in Central Africa. The response includes screening operations at border crossings, isolation facilities, and food assistance to affected populations.
Thursday, May 28, 2026
Gleevec Marked a Turning Point in Cancer Treatment 23 Years Ago
The Food and Drug Administration (FDA) approved Gleevec for leukemia treatment in 2001, marking a new phase in cancer care. The drug offered a targeted treatment, improving survival rates and quality of life for patients.
Thursday, May 28, 2026
Gleevec Marked a Turning Point in Cancer Treatment 23 Years Ago
The Food and Drug Administration (FDA) approved Gleevec for leukemia treatment in 2001, marking a new phase in cancer care. The drug offered a targeted treatment, improving survival rates and quality of life for patients.
Thursday, May 28, 2026
Cardiac screening studies find heart conditions in young women at rates comparable to men
Medical researchers have identified cardiac conditions in young women at frequencies similar to those found in young men, according to screening studies. The findings suggest current diagnostic protocols may miss significant numbers of at-risk women.
Thursday, May 28, 2026
Experimental pancreatic cancer pill extends survival in advanced cases
Researchers reported Sunday that an experimental pill helped patients with advanced pancreatic cancer survive longer than current treatments allow. The findings offer a potential new option for a disease that kills most patients within months of diagnosis.
Thursday, May 28, 2026
Federal Judge to Review $1.8 Billion Compensation Fund for Trump Administration
A federal judge has agreed to review a $1.8 billion fund established by the Trump administration to compensate individuals it says suffered wrongful treatment by the federal government. The fund's announcement sparked opposition across Republican and Democratic ranks.
Thursday, May 28, 2026
Experimental Pancreatic Cancer Pill Extends Survival in Clinical Trial
Researchers reported Sunday that an experimental pill extended survival for people with advanced pancreatic cancer, marking a potential advance against one of the most lethal malignancies.
Thursday, May 28, 2026